Expert Outlook: PACS Group Through The Eyes Of 5 Analysts

In the preceding three months, 5 analysts have released ratings for PACS Group PACS, presenting a wide array of perspectives from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 2 1 0 0
Last 30D 0 0 1 0 0
1M Ago 0 1 0 0 0
2M Ago 0 1 0 0 0
3M Ago 2 0 0 0 0

Analysts have recently evaluated PACS Group and provided 12-month price targets. The average target is $37.0, accompanied by a high estimate of $50.00 and a low estimate of $18.00. Experiencing a 19.57% decline, the current average is now lower than the previous average price target of $46.00.

price target chart

Deciphering Analyst Ratings: An In-Depth Analysis

The perception of PACS Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Lisa Gill JP Morgan Announces Neutral $18.00 -
Scott Fidel Stephens & Co. Lowers Overweight $31.00 $48.00
Lisa Gill JP Morgan Announces Overweight $40.00 -
David Macdonald Truist Securities Raises Buy $46.00 $44.00
A.J. Rice UBS Announces Buy $50.00 -

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PACS Group. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of PACS Group compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of PACS Group's stock. This comparison reveals trends in analysts' expectations over time.

For valuable insights into PACS Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on PACS Group analyst ratings.

Unveiling the Story Behind PACS Group

PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.

A Deep Dive into PACS Group's Financials

Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Over the 3 months period, PACS Group showcased positive performance, achieving a revenue growth rate of 29.08% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: PACS Group's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -1.11%, the company may face hurdles in effective cost management.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -3.12%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): PACS Group's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.28%, the company may face hurdles in achieving optimal financial performance.

Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 4.67, caution is advised due to increased financial risk.

How Are Analyst Ratings Determined?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!